1. Home
  2. GRFS vs IDCC Comparison

GRFS vs IDCC Comparison

Compare GRFS & IDCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRFS
  • IDCC
  • Stock Information
  • Founded
  • GRFS 1940
  • IDCC 1972
  • Country
  • GRFS Spain
  • IDCC United States
  • Employees
  • GRFS N/A
  • IDCC N/A
  • Industry
  • GRFS Biotechnology: Pharmaceutical Preparations
  • IDCC Multi-Sector Companies
  • Sector
  • GRFS Health Care
  • IDCC Miscellaneous
  • Exchange
  • GRFS Nasdaq
  • IDCC Nasdaq
  • Market Cap
  • GRFS 5.9B
  • IDCC 6.9B
  • IPO Year
  • GRFS 2006
  • IDCC N/A
  • Fundamental
  • Price
  • GRFS $8.39
  • IDCC $347.04
  • Analyst Decision
  • GRFS Hold
  • IDCC Strong Buy
  • Analyst Count
  • GRFS 1
  • IDCC 2
  • Target Price
  • GRFS $10.30
  • IDCC $412.50
  • AVG Volume (30 Days)
  • GRFS 779.1K
  • IDCC 363.1K
  • Earning Date
  • GRFS 01-01-0001
  • IDCC 10-30-2025
  • Dividend Yield
  • GRFS 1.70%
  • IDCC 0.81%
  • EPS Growth
  • GRFS N/A
  • IDCC 58.70
  • EPS
  • GRFS 0.64
  • IDCC 14.75
  • Revenue
  • GRFS $8,821,017,248.00
  • IDCC $928,587,000.00
  • Revenue This Year
  • GRFS $5.31
  • IDCC N/A
  • Revenue Next Year
  • GRFS $6.02
  • IDCC N/A
  • P/E Ratio
  • GRFS $16.23
  • IDCC $23.43
  • Revenue Growth
  • GRFS 7.31
  • IDCC 28.75
  • 52 Week Low
  • GRFS $6.19
  • IDCC $169.58
  • 52 Week High
  • GRFS $11.14
  • IDCC $412.60
  • Technical
  • Relative Strength Index (RSI)
  • GRFS 33.65
  • IDCC 47.29
  • Support Level
  • GRFS $8.33
  • IDCC $322.75
  • Resistance Level
  • GRFS $8.64
  • IDCC $345.46
  • Average True Range (ATR)
  • GRFS 0.21
  • IDCC 13.55
  • MACD
  • GRFS -0.00
  • IDCC -3.46
  • Stochastic Oscillator
  • GRFS 26.21
  • IDCC 38.21

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

About IDCC InterDigital Inc.

InterDigital Inc is a research and development company focused on wireless, video, Artificial Intelligence, and related technologies. It designs and develops technologies that enable connected, immersive experiences in a broad range of communications and entertainment products and services. The majority of revenue is generated from fixed-fee patent license agreements, with a smaller portion coming from variable royalty agreements. Geographically it operates in the United States, China, South Korea, Japan, Taiwan, and Europe, out of which the majority is from China.

Share on Social Networks: